Camlin Fine Sciences Ltd
NSE:CAMLINFINE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Camlin Fine Sciences Ltd
Note Receivable
Camlin Fine Sciences Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Camlin Fine Sciences Ltd
NSE:CAMLINFINE
|
Note Receivable
₹285.2m
|
CAGR 3-Years
34%
|
CAGR 5-Years
7%
|
CAGR 10-Years
17%
|
|
|
Navin Fluorine International Ltd
NSE:NAVINFLUOR
|
Note Receivable
₹70.1m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
|
|
Fine Organic Industries Ltd
NSE:FINEORG
|
Note Receivable
₹8.1m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Aarti Industries Ltd
NSE:AARTIIND
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Asian Paints Ltd
NSE:ASIANPAINT
|
Note Receivable
₹2.4B
|
CAGR 3-Years
363%
|
CAGR 5-Years
32%
|
CAGR 10-Years
-4%
|
|
|
Gujarat Fluorochemicals Ltd
NSE:FLUOROCHEM
|
Note Receivable
₹3.7B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Camlin Fine Sciences Ltd
Glance View
Camlin Fine Sciences Ltd. engages in the research, development, manufacture, and marketing of fine chemicals which are used as antioxidants, industrial chemicals, and aroma products. The company is headquartered in Mumbai, Maharashtra and currently employs 478 full-time employees. The company went IPO on 2015-01-20. The firm is a provider of antioxidants and shelf-life solutions, aroma ingredients, health and wellness, and performance chemicals. Its products include BHA, TBHQ and GUAIACOL BULK. The firm offers its products across various industries, including food and beverages, animal nutrition, pet food, aquaculture, bio-fuels, pharmaceuticals, dyes and pigments, petrochemicals and polymers. The company manufactures Methyl Vanillin which is sold under the Company’s brand name VanesseTM and Ethyl Vanillin, that is used in a range of applications, such as chocolates, ice creams, bakery products, incense sticks, perfumes, soaps, personal care and cosmetic products. Its performance chemicals business is involved in providing specialty chemicals, including Guaiacol, Veratrole, TBC, MEHQ, CME, HQEE, Hydroquinone and Catechol.
See Also
What is Camlin Fine Sciences Ltd's Note Receivable?
Note Receivable
285.2m
INR
Based on the financial report for Dec 31, 2025, Camlin Fine Sciences Ltd's Note Receivable amounts to 285.2m INR.
What is Camlin Fine Sciences Ltd's Note Receivable growth rate?
Note Receivable CAGR 10Y
17%
Over the last year, the Note Receivable growth was 79%. The average annual Note Receivable growth rates for Camlin Fine Sciences Ltd have been 34% over the past three years , 7% over the past five years , and 17% over the past ten years .
